Northern California Stroke Network Coordinating Center
NIH StrokeNet- NorCal Regional Coordinating Center RCC13
This program helps run clinical trials that test new ways to prevent, treat, and recover from stroke for people served by participating hospitals in Northern California.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project ID | NIH-11239812 on NIH RePORTER |
What this research studies
From my perspective as a patient, this center links hospitals and health systems across Northern California so stroke trials can be offered where people receive care. The University of California San Francisco team coordinates enrollment, data management, safety oversight, and communication between sites to keep trials moving smoothly. They focus on prevention, emergency treatments, and recovery, and work to include diverse groups such as veterans, children, and underrepresented communities. The center also supports training for clinicians and staff so more high-quality stroke studies can start and finish faster.
Who could benefit from this research
Good fit: Ideal candidates are people who have had a stroke, are at risk for stroke, or are receiving care at one of the participating Northern California hospitals and meet specific trial criteria.
Not a fit: People who live outside the participating region or who do not have a stroke-related condition may not see direct benefit from this coordinating center itself unless they join a specific trial.
Why it matters
Potential benefit: If successful, this could speed access to better stroke prevention, emergency care, and rehabilitation options for patients in the region.
How similar studies have performed: This effort builds on the national NIH StrokeNet model, which has supported multiple successful stroke clinical trials in the past.
Where this research is happening
San Francisco, United States
- University of California, San Francisco — San Francisco, United States (Active)
Researchers
- Principal investigator: Kim, Anthony Suyoung — University of California, San Francisco
- Study coordinator: Kim, Anthony Suyoung
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.